Literature DB >> 10450199

Bone marrow involvement in breast cancer detected by positron emission tomography.

C R Lewanski1, G R Kaplan, J Potter, P Richman, R F Ashford, W L Wong.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10450199      PMCID： PMC1297144          DOI： 10.1177/014107689909200410

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  9 in total

1.  Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

Authors:  T Jansson; J E Westlin; H Ahlström; A Lilja; B Långström; J Bergh
Journal:  J Clin Oncol       Date:  1995-06       Impact factor: 44.544

2.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Authors:  R L Wahl; K Zasadny; M Helvie; G D Hutchins; B Weber; R Cody
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

3.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Authors:  R L Wahl; L E Quint; R L Greenough; C R Meyer; R I White; M B Orringer
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

4.  Detection of bone marrow involvement in breast cancer with magnetic resonance imaging.

Authors:  S M Sanal; F W Flickinger; M J Caudell; R M Sherry
Journal:  J Clin Oncol       Date:  1994-07       Impact factor: 44.544

5.  Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.

Authors:  O E Nieweg; E E Kim; W H Wong; W F Broussard; S E Singletary; G N Hortobagyi; R S Tilbury
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

6.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.

Authors:  N C Gupta; J Maloof; E Gunel
Journal:  J Nucl Med       Date:  1996-06       Impact factor: 10.057

7.  MR imaging of diffuse bone marrow replacement in pediatric patients with cancer.

Authors:  C Ruzal-Shapiro; W E Berdon; M D Cohen; S J Abramson
Journal:  Radiology       Date:  1991-11       Impact factor: 11.105

8.  Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.

Authors:  S K Mukherji; W E Drane; A A Mancuso; J T Parsons; W M Mendenhall; S Stringer
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

9.  The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness.

Authors:  J N Ingle; D C Tormey; H K Tan
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860
  9 in total
  2 in total

1.  Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging.

Authors:  Kusai M Al-Muqbel
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

2.  Bone marrow uptake of 18F-fluorodeoxyglucose in Hodgkin lymphoma without bone involvement: comparison between patients with and without B symptoms.

Authors:  Rômulo Hermeto Bueno do Vale; Daniela Andrade Ferraro; Paulo Schiavom Duarte; Giovana Carvalho; Marcos Santos Lima; George Barbério Coura Filho; Marcelo Tatit Sapienza; Carlos Alberto Buchpiguel
Journal:  Radiol Bras       Date:  2018 Mar-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.